ARCHIVES

Tyrosine Kinase Inhibitor Encoraging For NSCLC

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing

October 8, 2010

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

Centers May Become More specialized, Klausner Tells AACI

April 26, 1996